Based on these results, and after treatment with epacadostat an inhibitor of IDO1, in combination with the PD-1 inhibitors, pembrolizumab and nivolumab, HNSCC showed moderate suppression [170]. The gene discussed is IDO1; the disease is head and neck squamous cell carcinoma.